A Brave New Mind - Psychedelic Medicine in Aotearoa
Psychedelic medicine is on its way to Aotearoa, and we're taking you on the journey. Join us each week as we ask the big questions, and ponder the potentials and pitfalls of this burgeoning field with local scientists and researchers, the big overseas names in the field, Kiwi clinicians, those gearing up to take therapeutic psychedelics into the mainstream, and more.
A Brave New Mind - Psychedelic Medicine in Aotearoa
Prof David Nutt - Calling out the lies
•
Dr Will Evans and Susi Maclean
•
Season 1
•
Episode 8
Professor David Nutt is the Chair of Neuropsychopharmacology at Imperial College London and a world-leading psychedelic researcher. He's a strong advocate for a rational, evidence based approach to psychedelics, and continues to, in his own words, 'call out the lies' about them, wherever he can.
David is currently Chair of DrugScience and President of the European Brain Council, has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. He is also the host of the very popular
The Drug Science Podcast.
We covered a lot of ground with David, including:
- his latest study, looking into MDMA and alcoholism
- his theory about why psychedelics appear to be especially effective in treating 'internalising disorders' like depression, anxiety and OCD
- the nature of consciousness and where psychedelics fit
- the risk that the high price tag for psychedelic assisted psychotherapy could leave it out of reach for most people and the role community healing could play